Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow

Journal of Cellular Physiology

Volumn 227, Issue 9, 2012, Pages 3234-3242

  Jaramillo Ferrada, Pamela A ^a   Wolvetang, Ernst J ^a   Cooper White, Justin J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BIOLOGICAL MARKER; CADHERIN; CD146 ANTIGEN; CD56 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; INTEGRIN; KRUPPEL LIKE FACTOR 4; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ALPHA CHAIN; AMNION; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL TYPE; CHONDROGENESIS; CHORION; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEDIATOR; MESENCHYMAL STROMA CELL; NUCLEOTIDE SEQUENCE; PLACENTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; STEM CELL; TERM BIRTH;

ADIPOGENESIS; AMNION; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CHORION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC MARKERS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PLACENTA; PREGNANCY;

EID: 84862074525     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24014     Document Type: Article

References (66)

1. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. 2007. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7: 11.
2. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K. 2008. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17: 1095-1107.
3. Battula VL, Treml S, Abele H, Buhring HJ. 2008. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76: 326-336.
4. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Muller I, Schewe B, Skutella T, Fibbe WE, Kanz L, Buhring HJ. 2009. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94: 173-184.
5. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. 2004. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22: 675-682.
6. Bernardo ME, Locatelli F, Fibbe WE. 2009. Mesenchymal stromal cells. Ann N Y Acad Sci 1176: 101-117.
7. Bieback K, Kern S, Kluter H, Eichler H. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634.
8. Brooke G, Tong H, Levesque JP, Atkinson K. 2008. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 17: 929-940.
9. Brooke G, Rossetti T, Pelekanos R, Ilic N, Murray P, Hancock S, Antonenas V, Huang G, Gottlieb D, Bradstock K, Atkinson K. 2009. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol 144: 571-579.
10. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. 2001. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402.
11. Caplan AI. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
12. Chang Y-J, Shih DT, Tseng C-P, Hsieh T-B, Lee D-C, Hwang S-M. 2006. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24: 679-685.
13. Chen C-P, Lee M-Y, Huang J-P, Aplin JD, Wu Y-H, Hu C-S, Chen P-C, Li H, Hwang S-M, Liu S-H, Yang YC. 2008. Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells 26: 550-561.
14. Costa M, Dottori M, Sourris K, Jamshidi P, Hatzistavrou T, Davis R, Azzola L, Jackson S, Lim SM, Pera M, Elefanty AG, Stanley EG. 2007. A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc 2: 792-796.
15. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. 1999. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14: 1115-1122.
16. Erices A, Conget P, Minguell JJ. 2000. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
17. Gao J, Caplan AI. 2003. Mesenchymal stem cells and tissue engineering for orthopaedic surgery. Chir Organi Mov 88: 305-316.
18. Halbleib JM, Nelson WJ. 2006. Cadherins in development: Cell adhesion, sorting, and tissue morphogenesis. Genes Dev 20: 3199-3214.
19. Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, Ingenito EP. 2011. Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev 20: 1779-1792.
20. Huang TF, Chen YT, Yang TH, Chen LL, Chiou SH, Tsai TH, Tsai CC, Chen MH, Ma HL, Hung SC. 2008. Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament. Cytotherapy 10: 806-814.
21. Huang HI, Chen SK, Ling QD, Chien CC, Liu HT, Chan SH. 2010. Multilineage Differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng A 16: 1491-1501.
22. Huppertz B. 2008. The anatomy of the normal placenta. J Clin Pathol 61: 1296-1302.
23. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH. 2004. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345.
24. Jo CH, Ahn HJ, Kim HJ, Seong SC, Lee MC. 2007. Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium. Cytotherapy 9: 316-327.
25. Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ. 2011. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: A comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res 346: 53-64.
26. Lee MY, Huang JP, Chen YY, Aplin JD, Wu YH, Chen CY, Chen PC, Chen CP. 2009. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS ONE 4: e6913.
27. Lepperdinger G, Brunauer R, Jamnig A, Laschober G, Kassem M. 2008. Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Gerontol 43: 1018-1023.
28. Lin NH, Menicanin D, Mrozik K, Gronthos S, Bartold PM. 2008. Putative stem cells in regenerating human periodontium. J Periodontal Res 43: 514-523.
29. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
30. Lo YM, Lau TK, Chan LY, Leung TN, Chang AM. 2000. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46: 1301-1309.
31. Malak TM, Bell SC. 1994. Differential expression of the integrin subunits in human fetal membranes. J Reprod Fertil 102: 269-276.
32. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. 2001. Isolation of human mesenchymal stem cells: Bone marrow versus umbilical cord blood. Haematologica 86: 1099-1100.
33. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F. 2006. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
34. Mariotti E, Mirabelli P, Abate G, Schiattarella M, Martinelli P, Fortunato G, Di Noto R, Del Vecchio L. 2008. Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference. Stem Cells Dev 17: 1039-1041.
35. Mihu CM, Mihu D, Costin N, Rus Ciuca D, Susman S, Ciortea R. 2008. Isolation and characterization of stem cells from the placenta and the umbilical cord. Rom J Morphol Embryol 49: 441-446.
36. Mihu CM, Rus Ciuca S, Soritau S, Susman S, Mihu D. 2009. Isolation and characterization of mesenchymal stem cells from the amniotic membrane. Rom J Morphol Embryol 50: 73-77.
37. Mouiseddine M, Mathieu N, Stefani J, Demarquay C, Bertho JM. 2008. Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus. Stem Cells Dev 17: 1165-1174.
38. Parolini O. 2008. Stem cells derived from placenta: Where do we stand? Tissue Engineering Part A 14: 780-780.
39. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. 2008. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
40. Pittenger MF. 2008. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 449: 27-44.
41. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
42. Polisetty N, Fatima A, Madhira SL, Sangwan VS, Vemuganti GK. 2008. Mesenchymal cells from limbal stroma of human eye. Mol Vis 14: 431-442.
43. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV. 2006. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 194: 664-673.
44. Portmann-Lanz CB, Schoeberlein A, Portmann R, Mohr S, Rollini P, Sager R, Surbek DV. 2010. Turning placenta into brain: Placental mesenchymal stem cells differentiate into neurons and oligodendrocytes. Am J Obstet Gynecol 202: 294.e1-294.e11.
45. Riekstina U, Cakstina I, Parfejevs V, Hoogduijn M, Jankovskis G, Muiznieks I, Muceniece R, Ancans J. 2009. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev 5: 378-386.
46. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. 2008. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 314: 1937-1944.
47. Rus Ciuca D, Soritau O, Susman S, Pop VI, Mihu CM. 2011. Isolation and characterization of chorionic mesenchyal stem cells from the placenta. Rom J Morphol Embryol 52: 803-808.
48. Salem HK, Thiemermann C. 2010. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28: 585-596.
49. Segat D, Comai R, Di Marco E, Strangio A, Cancedda R, Franzi AT, Tacchetti C. 2002. Integrins alpha(6A)beta 1 and alpha(6B)beta 1 promote different stages of chondrogenic cell differentiation. J Biol Chem 277: 31612-31622.
50. Segawa Y, Muneta T, Makino H, Nimura A, Mochizuki T, Ju YJ, Ezura Y, Umezawa A, Sekiya I. 2009. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles. J Orthop Res 27: 435-441.
51. Shetty P, Cooper K, Viswanathan C. 2010. Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci 4: 14-24.
52. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O. 2007. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1: 296-305.
53. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.
54. Sotiropoulou PA, Perez SA, Papamichail M. 2007. Clinical grade expansion of human bone marrow mesenchymal stem cells. Methods Mol Biol 407: 245-263.
55. Squillaro T, Hayek G, Farina E, Cipollaro M, Renieri A, Galderisi U. 2008. A case report: Bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis. J Cell Biochem 103: 1877-1885.
56. Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW. 2003. Maternal cell microchimerism in newborn tissues. J Pediatr 142: 31-35.
57. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
58. Stolzing A, Jones E, McGonagle D, Scutt A. 2008. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 129: 163-173.
59. Streuli CH. 2009. Integrins and cell-fate determination. J Cell Sci 122: 171-177.
60. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H, Hozack WJ, Manner PA, Danielson KG, Tuan RS. 2003. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21: 681-693.
61. Valtieri M, Sorrentino A. 2008. The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol 217: 296-300.
62. Vincent T, Mechti N. 2005. Extracellular matrix in bone marrow can mediate drug resistance in myeloma. Leuk Lymphoma 46: 803-811.
63. Wagner W, Ho AD, Zenke M. 2010. Different facets of aging in human mesenchymal stem cells. Tissue Eng B Rev 16: 445-453.
64. Wulf GG, Viereck V, Hemmerlein B, Haase D, Vehmeyer K, Pukrop T, Glass B, Emons G, Trumper L. 2004. Mesengenic progenitor cells derived from human placenta. Tissue Eng 10: 1136-1147.
65. Zhang ZY, Teoh SH, Chong MS, Schantz JT, Fisk NM, Choolani MA, Chan J. 2009. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27: 126-137.
66. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.